An­tios re­port­ed­ly shut down; Clene's long-term ALS da­ta; Keytru­da, Lenvi­ma's lung can­cer fail­ures

Plus, Val­ne­va signs US con­tract for Ix­i­aro, and Pierre Fab­re inks a can­cer deal with Ver­nalis.

He­pati­tis B start­up An­tios Ther­a­peu­tics shuts down — re­port

…

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER